Validation Study of the OHIO Chamber in Patients with Japanese Cedar Pollinosis

被引:28
|
作者
Hashiguchi, Kazuhiro [1 ]
Tang, Huaipeng [2 ]
Fujita, Toshio [3 ]
Suematsu, Kiyochika [4 ]
Tsubaki, Shigekazu [5 ]
Nagakura, Hitoshi [6 ]
Kitajima, Sei [7 ]
Gotoh, Minoru [9 ]
Okubo, Kimihiro [8 ]
机构
[1] Kitasato Inst Hosp, Dept Otolaryngol, Minato Ku, Tokyo 1088642, Japan
[2] Shinryo Corp, Ctr Res & Dev, Tsukuba, Ibaraki, Japan
[3] Shinryo Corp, Engn & Construct Div 1, Tokyo, Japan
[4] Tokyo Res Ctr Clin Pharmacol Co Ltd, Chamber Business Dept, Tokyo, Japan
[5] Samoncho Clin, Tokyo, Japan
[6] Nagakura Allergy Clin, Tokyo, Japan
[7] Kitajima Otolaryngol Clin, Tokyo, Japan
[8] Nippon Med Sch, Dept Otolaryngol, Tokyo 113, Japan
[9] Hokusoh Hosp, Nippon Med Sch, Dept Otolaryngol, Chiba, Japan
关键词
Allergen exposure; Clinical trial; Japanese cedar pollen; Japanese patients; OHIO Chamber; Seasonal allergic rhinitis; Validation study; SEASONAL ALLERGIC RHINITIS; ENVIRONMENTAL EXPOSURE UNIT; GRASS-POLLEN; PLACEBO; CETIRIZINE; CHALLENGE; ONSET; HYDROCHLORIDE; INHALATION; SYMPTOMS;
D O I
10.1159/000189197
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: An artificial exposure chamber (OHIO Chamber), which allows dispersal of a fixed concentration of Japanese cedar (JC) pollen under stable conditions, was constructed. This study was conducted to identify the exposure conditions assuring validity of the clinical tests conducted using this chamber. Methods: Twenty-four adult patients with JC pollinosis were exposed to different concentrations of JC pollen: 0 (only during the summer period), 4,000, 8,000 and 12,000 grains/m(3), and the nasal and ocular symptoms were self-assessed during a 4-hour period of exposure. The amount of nasal discharge was measured and the sneezing frequency was recorded. This study was conducted twice during the summer and winter periods, i.e. non-pollen seasons. The reproducibility of the symptoms between the two seasons was assessed. Results: None of the subjects developed any symptom at the pollen concentration of 0 grains/m(3). No significant differences in the time to the onset of symptoms were found between the summer and winter study, regardless of the pollen concentration. There were no significant differences between the summer and winter study in the total symptom score and total nasal symptom score at any pollen concentration, suggesting the very favorable reproducibility of symptoms. Conclusions: Efficient and reproducible results are obtained in patients exposed to JC pollen in the OHIO Chamber. The results suggest the conditions of JC pollen exposure have scientific validity and the OHIO Chamber has the potential to contribute significantly to basic and clinical studies of JC pollinosis. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:141 / 149
页数:9
相关论文
共 50 条
  • [1] Validation studies of the OHIO Chamber in patients with Japanese cedar pollinosis
    Hashiguchi, K.
    Tang, H.
    Suematsu, K.
    Tsubaki, S.
    Gotoh, M.
    Okubo, K.
    ALLERGY, 2008, 63 : 345 - 345
  • [2] Therapeutic effect of bilastine in Japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber)
    Hashiguchi, Kazuhiro
    Wakabayashi, Ken-ichiro
    Togawa, Michinori
    Saito, Akihiro
    Okubo, Kimihiro
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (01) : 123 - 131
  • [3] Evaluation of Montelukast for the Treatment of Children With Japanese Cedar Pollinosis Using an Artificial Exposure Chamber (OHIO Chamber)
    Hashiguchi, Kazuhiro
    Okubo, Kimihiro
    Inoue, Yoichi
    Numaguchi, Hirotaka
    Tanaka, Kumi
    Oshima, Nobuyuki
    Mehta, Anish
    Nishida, Chisato
    Saito, Itori
    Philip, George
    ALLERGY & RHINOLOGY, 2018, 9
  • [4] PRANLUKAST DRY SYRUP INHIBITS SYMPTOMS OF JAPANESE CEDAR POLLINOSIS IN CHILDREN USING OHIO CHAMBER
    Wakabayashi, K.
    Hashiguchi, K.
    Okubo, K.
    RESPIROLOGY, 2012, 17 : 104 - 104
  • [5] Pranlukast dry syrup inhibits symptoms of Japanese cedar pollinosis in children using OHIO Chamber
    Wakabayashi, Ken-ichiro
    Hashiguchi, Kazuhiro
    Kanzaki, Sho
    Fujioka, Masato
    Tanaka, Nobuaki
    Kawashima, Kayoko
    Suematsu, Kiyochika
    Yamamotoya, Hajime
    Iwasaki, Manabu
    Gotoh, Minoru
    Horibe, Seiji
    Naito, Kensei
    Okubo, Kimihiro
    ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (01) : 102 - 109
  • [6] Asthma in Patients With Japanese Cedar Pollinosis
    Tanaka, Akihiko
    Minoguchi, Kenji
    Pawankar, Ruby
    Adachi, Mitsuru
    WORLD ALLERGY ORGANIZATION JOURNAL, 2012, 5
  • [7] Placebo-controlled study with OHIO chamber of prophylactic pranlukast for children with Japanese cedar pollinosis: TOPIC-J III study
    Hosoya, Kei
    Masuno, Satoru
    Hashiguchi, Kazuhiro
    Okubo, Kimihiro
    JOURNAL OF DRUG ASSESSMENT, 2014, 3 (01) : 51 - 59
  • [8] Efficacy of Omalizumab in patients with Japanese cedar pollinosis
    Ogino, Satoshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 45P - 45P
  • [9] Evaluation of montelukast for the treatment of children with Japanese cedar pollinosis using an artificial exposure chamber (OHIO chamber) (vol 9, pg 1, 2018)
    Hashiguchi, K.
    Okubo, K.
    Inoue, Y.
    ALLERGY & RHINOLOGY, 2018, 9
  • [10] Influence of daytime sleepiness on pollinosis symptom and QOL in patients with Japanese cedar pollinosis
    Kato, C.
    Takeuchi, N.
    Ito, M.
    Minami, Y.
    Ogino, S.
    Arimoto, H.
    Irifune, M.
    Iwata, N.
    Ookawauchi, I
    Kikumori, H.
    Seo, R.
    Takeda, M.
    Tamaki, A.
    Baba, K.
    Nose, M.
    ALLERGY, 2009, 64 : 334 - 334